This announcement is a separate document:
基石藥業-B：自願公告 - 基石藥業宣佈泰吉華（阿伐替尼片）被納入2023年國家醫保藥品目錄
CSTONE PHARMA-B: VOLUNTARY ANNOUNCEMENT - CSTONE ANNOUNCES INCLUSION OF AYVAKIT (AVAPRITINIB) IN 2023 CHINA''S NATIONAL REIMBURSEMENT DRUG LIST
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.